| COVID-19 associated pulmonary aspergillosis (CAPA)—from immunology to treatment A Arastehfar, A Carvalho, FL van de Veerdonk, JD Jenks, P Koehler, ... Journal of Fungi 6 (2), 91, 2020 | 393 | 2020 |
| The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin M Hoenigl, R Sprute, M Egger, A Arastehfar, OA Cornely, R Krause, ... Drugs 81, 1703-1729, 2021 | 218 | 2021 |
| Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the … M Hoenigl, J Salmanton-García, TJ Walsh, M Nucci, CF Neoh, JD Jenks, ... The Lancet Infectious Diseases 21 (8), e246-e257, 2021 | 215 | 2021 |
| Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of … J Prattes, J Wauters, DR Giacobbe, J Salmanton-García, J Maertens, ... Clinical Microbiology and Infection 28 (4), 580-587, 2022 | 168 | 2022 |
| Drug-resistant fungi: an emerging challenge threatening our limited antifungal armamentarium A Arastehfar, T Gabaldón, R Garcia-Rubio, JD Jenks, M Hoenigl, ... Antibiotics 9 (12), 877, 2020 | 152 | 2020 |
| Aspergillus fumigatus and aspergillosis: From basics to clinics A Arastehfar, A Carvalho, J Houbraken, L Lombardi, R Garcia-Rubio, ... Studies in mycology 100 (1), 100115-100115, 2021 | 148 | 2021 |
| Treatment of aspergillosis JD Jenks, M Hoenigl Journal of Fungi 4 (3), 98, 2018 | 143 | 2018 |
| Breakthrough invasive fungal infections: Who is at risk? JD Jenks, OA Cornely, SCA Chen, GR Thompson III, M Hoenigl Mycoses 63 (10), 1021-1032, 2020 | 126 | 2020 |
| Development and Validation of the San Diego Early Test Score to Predict Acute and Early HIV Infection Risk in Men Who Have Sex With Men LSJ Hoenigl M, Weibel N, Mehta SR, Anderson CM, Jenks J, Green N, Gianella S ... Clinical Infectious Diseases, 2015 | 112 | 2015 |
| Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy JD Jenks, HJF Salzer, J Prattes, R Krause, D Buchheidt, M Hoenigl Drug design, development and therapy, 1033-1044, 2018 | 111 | 2018 |
| Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy JD Jenks, SL Reed, D Seidel, P Koehler, OA Cornely, SR Mehta, ... International journal of antimicrobial agents 52 (5), 706-712, 2018 | 84 | 2018 |
| Point‐of‐care diagnosis of invasive aspergillosis in non‐neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus‐specific Lateral … JD Jenks, SR Mehta, R Taplitz, S Aslam, SL Reed, M Hoenigl Mycoses 62 (3), 230-236, 2019 | 80 | 2019 |
| Invasive aspergillosis as an under-recognized superinfection in COVID-19 GR Thompson Iii, OA Cornely, PG Pappas, TF Patterson, M Hoenigl, ... Open forum infectious diseases 7 (7), ofaa242, 2020 | 77 | 2020 |
| Broad spectrum triazoles for invasive mould infections in adults: Which drug and when? JD Jenks, SR Mehta, M Hoenigl Medical mycology 57 (Supplement_2), S168-S178, 2019 | 68 | 2019 |
| Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches JD Jenks, HH Nam, M Hoenigl Mycoses 64 (9), 1002-1014, 2021 | 63 | 2021 |
| Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008–2019 JD Jenks, D Seidel, OA Cornely, S Chen, S van Hal, C Kauffman, ... Clinical Microbiology and Infection 26 (6), 784. e1-784. e5, 2020 | 59 | 2020 |
| Bronchoalveolar lavage Aspergillus Galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary Aspergillosis in … JD Jenks, SR Mehta, R Taplitz, N Law, SL Reed, M Hoenigl Journal of Infection 78 (3), 249-259, 2019 | 55 | 2019 |
| Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope® registry JD Jenks, D Seidel, OA Cornely, S Chen, S van Hal, C Kauffman, ... Mycoses 63 (5), 437-442, 2020 | 53 | 2020 |
| Antibiotic resistance needs global solutions J Jenks The Lancet Infectious Diseases 14 (7), 550, 2014 | 52* | 2014 |
| Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary … JD Jenks, J Prattes, J Frank, B Spiess, SR Mehta, T Boch, D Buchheidt, ... Clinical Infectious Diseases 73 (7), e1737-e1744, 2021 | 50 | 2021 |
Martin HoeniglAssociate Professor of Translational Mycology, Medical University of Graz, AustriaVerified email at medunigraz.at
